Mankind Pharma Limited (NSE:MANKIND)

Mankind Pharma Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 27, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	973,338	1,000,400	921,654	-	-	-
Market Cap Growth	8.54%	8.54%	-	-	-	-
Enterprise Value	1,038,357	960,198	902,241	-	-	-
Last Close Price	2358.30	2424.75	2300.75	-	-	-
PE Ratio	48.04	50.25	48.18	-	-	-
Forward PE	46.42	45.13	43.88	-	-	-
PS Ratio	7.97	8.20	8.92	-	-	-
PB Ratio	6.68	6.87	9.63	-	-	-
P/TBV Ratio	-	-	12.00	-	-	-
P/FCF Ratio	49.85	51.24	50.17	-	-	-
P/OCF Ratio	40.33	41.45	42.82	-	-	-
PEG Ratio	3.13	2.64	1.91	-	-	-
EV/Sales Ratio	8.51	7.87	8.73	-	-	-
EV/EBITDA Ratio	34.27	31.82	35.57	-	-	-
EV/EBIT Ratio	43.10	40.06	41.93	-	-	-
EV/FCF Ratio	53.18	49.18	49.11	-	-	-
Debt / Equity Ratio	0.58	0.58	0.02	0.02	0.14	0.06
Debt / EBITDA Ratio	2.82	2.82	0.08	0.09	0.44	0.16
Debt / FCF Ratio	4.36	4.36	0.11	0.17	1.94	0.34
Asset Turnover	0.62	0.62	0.95	0.93	1.00	1.09
Inventory Turnover	1.91	1.91	2.18	1.84	1.69	1.77
Quick Ratio	0.67	0.67	2.02	1.14	0.65	1.78
Current Ratio	1.23	1.23	3.10	2.32	1.68	2.89
Return on Equity (ROE)	16.62%	16.62%	22.58%	18.79%	25.99%	30.30%
Return on Assets (ROA)	7.54%	7.54%	12.41%	10.53%	14.76%	17.37%
Return on Capital (ROIC)	9.12%	9.12%	15.30%	13.24%	18.56%	22.22%
Return on Capital Employed (ROCE)	10.80%	10.80%	21.90%	20.20%	28.10%	31.70%
Earnings Yield	2.05%	1.99%	2.08%	-	-	-
FCF Yield	2.01%	1.95%	1.99%	-	-	-
Buyback Yield / Dilution	-0.87%	-0.87%	-0.14%	-0.00%	-	-
Total Shareholder Return	-	-0.87%	-0.14%	-0.00%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.